Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Techne

57.09
+3.095.72%
Post-market: 57.090.00000.00%19:27 EDT
Volume:1.44M
Turnover:82.12M
Market Cap:8.95B
PE:124.11
High:57.43
Open:54.89
Low:54.31
Close:54.00
52wk High:80.95
52wk Low:46.01
Shares:156.77M
Float Shares:154.93M
Volume Ratio:0.93
T/O Rate:0.93%
Dividend:0.32
Dividend Rate:0.56%
EPS(TTM):0.4600
EPS(LYR):0.4660
ROE:3.68%
ROA:2.92%
PB:4.66
PE(LYR):122.52

Loading ...

Bio-Techne Corp. Stock Advances 5.7%, Outperforms Competitors

Dow Jones
·
9 hours ago

NEXION TECH (08420) Reports Interim Results: Shareholders' Loss of HK$1.318 Million, Down 63.07% Year-on-Year

Stock News
·
Yesterday

Bio-Techne Corporation Reports 5% Increase in FY 2025 Net Sales to $1.2 Billion, Sees 56% Drop in Net Earnings Due to Non-Recurring Losses

Reuters
·
Yesterday

Digital Asset Exchange Company LO:TECH Completes $5 Million Seed Round Funding, Led by 13books Capital

Blockbeats
·
Aug 21

Bio-Techne Raised to Buy From Neutral by Citigroup

Dow Jones
·
Aug 21

Citigroup Upgrades Bio-Techne to Buy From Neutral, Adjusts Price Target to $70 From $55

MT Newswires Live
·
Aug 21

Bio-Techne upgraded to Buy from Neutral at Citi

TIPRANKS
·
Aug 21

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 20

Bio-Techne Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Aug 15

Bio-Techne Corporation, in Partnership with Wilson Wolf and CellReady, Awards $300,000 G-Rex® Grant to Gates Institute for CAR T-Cell Manufacturing Platform Development

Reuters
·
Aug 14

Bio-Techne Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 13

TS TECH Co., Ltd. Reports Decline in Q1 FY2026 Financial Results

TIPRANKS
·
Aug 08

RBC Capital Sticks to Its Hold Rating for Bio-Techne (TECH)

TIPRANKS
·
Aug 08

Leerink Partners Adjusts Bio-Techne Price Target to $75 From $80, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

RBC Lowers Price Target on Bio-Techne to $61 From $63, Keeps Sector Perform Rating

MT Newswires Live
·
Aug 07

Bio-Techne Reports Solid Q4 2025 Results Amid Strategic Shift

TIPRANKS
·
Aug 07

Bio-Techne beats quarterly estimates, flags tariff uncertainty for customers

Reuters
·
Aug 07

Stock Track | Bio-Techne Plummets 5.30% Despite Beating Q4 Earnings Estimates

Stock Track
·
Aug 06

Bio-Techne Corp Exec Says China Surprised Positively, Increasing Low Double Digits in Q4 as the Region Returned to Growth Ahead of Anticipated Tariff Impact - Conf Call

THOMSON REUTERS
·
Aug 06

Bio-Techne Corp Exec Says Co's Total Exposure to Nih Funded Research Is in Low Single Digits Below Co's Prior Estimates of 5% to 6% - Conf Call

THOMSON REUTERS
·
Aug 06